Ferriprotoporphyrin IX crystallization pathway

The Ferriprotoporphyrin IX crystallization pathway is a vital metabolic process employed by Plasmodium parasites to detoxify the byproduct of hemoglobin digestion [PMID: 17651410]. During the intraerythrocytic stage, the parasite consumes host hemoglobin, releasing large quantities of free heme (ferriprotoporphyrin IX), which is highly toxic due to its ability to generate reactive oxygen species and disrupt lipid membranes [PMID: 24511230]. To survive, the parasite sequesters this heme into an insoluble, chemically inert crystalline form known as hemozoin, or malaria pigment [PMID: 18248344]. This biomineralization process occurs within the parasite's acidic digestive vacuole and is often mediated by lipids or specific proteins like the Heme Detoxification Protein (HDP) [PMID: 19214180]. This pathway is the primary target for several classes of antimalarial drugs, most notably the quinolines like chloroquine and quinine [PMID: 11375454]. These drugs interfere with the crystallization process by binding to heme monomers or the surface of growing crystals, resulting in the accumulation of toxic free heme that ultimately kills the parasite [PMID: 15917916]. Understanding this pathway is crucial for developing new treatments, especially as resistance to traditional quinoline drugs continues to spread globally [PMID: 21107324].

Other names

Hemozoin formation pathwayHeme detoxification pathwayβ-hematin crystallizationMalaria pigment formationHeme polymerization pathway

Inhibition of ferriprotoporphyrin IX polymerization into hemozoin, leading to the accumulation of toxic free heme which causes membrane damage and parasite lysis.